Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

How a scrappy African startup could forever change the world of vaccines

Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?

WEKU

Dow Jones Futures Rise, Tesla Bounces After Leading Growth Sell-Off; 5 Stocks Near Buy Points

Tesla bounced early after leading a growth sell-off with Moderna and Nvidia. Many industrial and energy plays are thriving

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Biotech Stock to Buy Over Moderna This December

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA’s growth, the industry prospects look bright. Therefore, investors looking to invest in biotech stocks could consider buying Biogen (BIIB) and Jazz…

StockNews.com

Stock Market Feels Winter Chill; Disney No Longer Happiest Place On Earth; Musk Monday Madness

Disney weighed on the Dow Jones after Avatar 2 missed box office numbers.

Investors Business Daily

Dow Jones Falls As Stock Market Continues To Drop; Tesla Down After Elon Musk Twitter Poll

The Dow Jones Industrial Average fell Monday after last week's heavy losses. Tesla stock jumped early on Elon Musk's Twitter poll that said he should step down, but quickly reversed lower.

Investors Business Daily

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

IBD Stock Of The Day Vertex Eyes A Brighter 2023 On Moderna, Crispr Plans

Vertex is the IBD Stock Of The Day. The FDA signed off on its newest study in cystic fibrosis, but VRTX stock is trading sideways.

Investors Business Daily

Moderna mRNA melanoma vaccine may be 'the penicillin moment' in cancer treatment, researchers say

A world-first melanoma vaccine which personalises treatments for patients may put an end to melanoma as a "death sentence", according to Australian experts.

ABC News

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

The Independent UK

Has Moderna successfully developed a personalised vaccine against melanoma? Maybe

Moderna has partnered with another drug company to produce a personalised vaccine against melanoma for people at risk of dying.

The New Daily

Moderna Stock Shows Surprising Strength; Key Rating Upgraded

A Relative Strength Rating upgrade for Moderna stock shows improving technical performance.

Investors Business Daily

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Fortune

Dow Jones Rallies; Elon Musk Loses This Title As Tesla Tumbles; Bitcoin Up Amid Sam Bankman-Fried Arrest

The Dow Jones moved higher. Tesla CEO Elon Musk lost a famous title. Bitcoin rose after the Sam Bankman-Fried arrest. Moderna stock jumped.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Mic

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Investors Business Daily

Stock Market Rally, New Breakouts Fade At Midday As CPI Enthusiasm Wanes

The stock market's reaction to the inflation data was swift and decisive.

The Independent UK

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

Investors Business Daily

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

AAP

Work starts on nation-first mRNA facility

Biotech giant Moderna's first mRNA vaccine facility in Australia is due to open in 2024, and will produce 100 million vaccine doses per year.

Tribune News Service

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

The Guardian - UK

Former vaccines chief sounds warning about UK pandemic readiness

Kate Bingham raises concerns to committee of MPs as head of UKHSA suggests Covid could be on rise again

Al Jazeera

Racing to develop Africa’s next-gen vaccines before new pandemic

How scientists across Africa plan to use mRNA technology to fight diseases and tackle inequities in global health.

The Independent UK

Universal flu vaccine could be ready for human use in two years – expert

The US researchers have created a vaccine based on the same mRNA technology used in the Covid-19 jabs from Moderna and Pfizer.

Reuters

Researchers test mRNA technology for universal flu vaccine

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.